| This week's sponsor is Premier Research. | | | Beyond Intensity: The Full Impact of Fibromyalgia Pain
Patient-reported outcomes drive fibromyalgia drug research, and pain intensity is one measure of many. Download our white paper to gauge the many related symptoms. Premier Research. It's what we do. Best. |
Today's Rundown Merck inks $394M takeover of oncolytic virus play Viralytics Ipsen joins Arix’s growing pool of pharma partners Medigene gets OK for first trial of T-cell receptor therapy [Sponsored] Optimizing Humanized Model Selection for Enhanced Preclinical Immunotherapy Assessment Arcus Biosciences eyes $100M IPO Johnson & Johnson beefs up its surgery robotics tech with acquisition of French company Sanofi again denies Dengvaxia refund request as Philippine officials prep lawsuit Featured Story | | | Wednesday, February 21, 2018 Merck is set to pay $394 million to acquire Viralytics. The takeover will give Merck control of an oncolytic immunotherapy that Viralytics is testing in combination with Keytruda in early-phase trials. |
|
|
| This week's sponsor is NYCEDC. | | | |
Top Stories Wednesday, February 21, 2018 Ipsen has become the latest drugmaker to start working with Arix Bioscience. The French biopharma follows Fosun, Takeda and UCB to become the fourth company to secure a connection to Arix’s stable of startups. Wednesday, February 21, 2018 Medigene has been given a green light by regulators in Germany to start human trials of MDG1011, the lead candidate to come out of its modified T-cell program. Tuesday, February 20, 2018 Tumor-bearing humanized models are vital preclinical platforms for assessing human-specific immunotherapies. Review immediately transferable humanized model strategies for accelerating immunotherapy drug discovery programs. Wednesday, February 21, 2018 Mere months after bagging $107 million in its series C round, Arcus Biosciences is teeing up for a $100 million IPO, which will drive the clinical development of its lead assets into 2020. Wednesday, February 21, 2018 Johnson & Johnson is beefing up its presence in the robotic surgery arena with the acquisition by its unit Apsis of French robot-assisted surgery company Orthotaxy for an undisclosed price. Wednesday, February 21, 2018 After two refusals from Sanofi to provide a refund for the controversial Dengvaxia program, officials in the Philippines say they are getting ready to sue. | This week's sponsor is ExL Events. | | | |
Resources Sponsored by: Reprints Desk The competitive landscape in medical device R&D is tough. And simply investing in R&D is no guarantee for profitability. So how do you accelerate time-to-market? Presented by: Box and USDM Life Sciences Learn how biopharma and medical device companies can now collaborate on, manage and distribute regulated clinical, lab and manufacturing content in Box. That means all of your content is standardized on a single content repository that meets regulatory and compliance standards, so you can eliminate inefficient silos, enable seamless collaboration and accelerate the validation process. Sponsored by: RBC Wealth Management Employee stock option trading & administration, Restricted stock transactions (Rule 144), Affiliated trading plans (10b5-1), Directed share plans, Equity comp plan administration — private to public Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Presented by: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Presented by: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented by: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented by: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented by: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored by: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Drug Approval, Manufacturing Quality & Regulation 2018 | Online MIXiii-Biomed 2018 May 15-17, 2018 | Tel-Aviv, Israel BioBasics: Biotech for the Non-Scientist March 29-30, 2018 | Boston, MA PEGS: The Essential Protein Engineering Summit April 30-May 4 | Boston, MA Partnering for Growth 2018 March 20th | 7:30 am-6 pm
March 21st | 7:30 am-1:15 pm Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA | Register and start preparing Today! | 